IPO Databook: Medcaptain Medical Technology (2041 HK) - Aug 2026

130 Views22 Aug 2026 10:13

SUMMARY

Medcaptain Medical Technology is a global medical device provider across 140+ countries. The IPO funds R&D, manufacturing expansion, and global sales and marketing.
Revenue increased to RMB1,619.2 million in 2025, with gross profit margin improving to 53.7%, and a net profit of RMB50.7 million.
The company reported RMB1,619,152 thousand revenue and RMB50,738 thousand profit for 2025, with a 1.64 current ratio.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.

Try Now

Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

SMARTKARMA PREVIEW PASS

By signing up, you agree to our
Terms of Use and Privacy Policy.

Already have an account? Sign In Now

Discussions

(Paid Plans Only)

Price Chart(Sign Up to Access)

Insight Stream